Iryna Fediak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Iryna Fediak has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
Ivano-Frankivsk National Medical University
2 shared publications- Andrii Andriiovych Mykhailov
Bogomolets National Medical University of the Ministry of Health of Ukraine, Kyiv, Ukraine
1 shared publication Diana Shybista
1 shared publication- I. V. Oktysiuk
Івано-Франківський національний медичний університет
1 shared publication Ivano-Frankivsk Archeparchy Of The Ugcc
1 shared publication- Liudmyla Konoshevych
Bogomolets National Medical University
1 shared publication
Latest Publications
- Open Access
- 8 December 2025
- Published by National University of Pharmacy in News of Pharmacy
- Vol. 110 (2) , 28-37
Analysis of the retail pharmaceutical market of analgesic drugs Meloxicam and Nalbuphine included in military first aid kits since the beginning of hostilities in Ukraine
Aim. To analyze the range and physical and socio-economic availability of analgesic drugs (ADs) based on the international nonproprietary names (INN) Meloxicam (M01AC06) and Nalbuphine (N02AF02), which have been or are currently included in military first aid kits since the beginning of hostilities in Ukraine. Materials and methods. The study used data from the State Register of Medicinal Products of Ukraine and the online drug search and reservation service Tabletki.ua for May 2025. Methods of comparison, systematization, and statistical analysis of prices and availability in pharmacies in Ivano-Frankivsk were applied, using the Pearson’s correlation coefficient (PCC) and the interquartile range (IQR). Results. Analgesic drugs with INN “Meloxicam” used in the form of tablets or ampoules in the individual military first aid kit (IMFAK) or other first-aid kits for military needs were represented by a wider range in the local retail market and were more affordable than INN “Nalbuphine”. Thus, according to the analysis, as of May 2025, the pharmaceutical market of Ivano-Frankivsk offered 29 trade names (TNs) of Meloxicam and 7 TNs of Nalbuphine. The PCC calculation showed no linear relationship between the price and the number of pharmacies offering the drugs studied, while the IQR coefficient indicated the market stability for both INNs. In general, drugs produced by Ukrainian manufacturers were found to be the most affordable. Conclusions. The range of analgesic drugs based on Meloxicam is broader than that of Nalbuphine. The economic feasibility of using Meloxicam, along with its higher safety applications, has been confirmed by price stability and a greater number of the market offers in the pharmaceutical sector.
- 8 December 2025
- Published by National University of Pharmacy in News of Pharmacy
- Vol. 110 (2) , 28-37
Open AccessAnalysis of the retail pharmaceutical market of analgesic drugs Meloxicam and Nalbuphine included in military first aid kits since the beginning of hostilities in Ukraine
Aim. To analyze the range and physical and socio-economic availability of analgesic drugs (ADs) based on the international nonproprietary names (INN) Meloxicam (M01AC06) and Nalbuphine (N02AF02), which have been or are currently included in military first aid kits since the beginning of hostilities in Ukraine. Materials and methods. The study used data from the State Register of Medicinal Products of Ukraine and the online drug search and reservation service Tabletki.ua for May 2025. Methods of comparison, systematization, and statistical analysis of prices and availability in pharmacies in Ivano-Frankivsk were applied, using the Pearson’s correlation coefficient (PCC) and the interquartile range (IQR). Results. Analgesic drugs with INN “Meloxicam” used in the form of tablets or ampoules in the individual military first aid kit (IMFAK) or other first-aid kits for military needs were represented by a wider range in the local retail market and were more affordable than INN “Nalbuphine”. Thus, according to the analysis, as of May 2025, the pharmaceutical market of Ivano-Frankivsk offered 29 trade names (TNs) of Meloxicam and 7 TNs of Nalbuphine. The PCC calculation showed no linear relationship between the price and the number of pharmacies offering the drugs studied, while the IQR coefficient indicated the market stability for both INNs. In general, drugs produced by Ukrainian manufacturers were found to be the most affordable. Conclusions. The range of analgesic drugs based on Meloxicam is broader than that of Nalbuphine. The economic feasibility of using Meloxicam, along with its higher safety applications, has been confirmed by price stability and a greater number of the market offers in the pharmaceutical sector.
- Open Access
- 4 September 2025
- Published by National University of Pharmacy in Social Pharmacy in Health Care
- Vol. 11 (3) , 37-47
The introduction of electronic prescriptions in Ukraine as an important component of the electronic healthcare system: the experience of pharmacists
The electronic prescription plays an important role in the digitalization of the healthcare system in Ukraine and is an important tool for managing the supply of medicines. The introduction of e-prescriptions brings the national healthcare system of Ukraine in line with international standards, in particular in the context of European integration obligations. The e-prescription provides transparency, accounting and control of the turnover of prescription drugs, contributes to the rationalization of pharmacotherapy and increases the responsibility of all participants in this process. Aim. To analyze the impact of e-prescriptions on the work of pharmacists, assess the advantages and problems they face during their introduction, as well as determine future development directions for the e-prescription system to improve the efficiency of pharmaceutical services. Materials and methods. The methods used included questionnaire surveys, analysis and synthesis, formal-logical, semantic, comparative, and systemic methods. The data analysis was performed using Microsoft Office Excel and STATISTICA 12. Results and discussion. Our study found that the level of satisfaction among pharmacists with the e-prescription system implemented in Ukraine was quite high, with an average score of 7.79±2.02. According to the survey results, the average value of the number of e-prescriptions dispensed by one pharmacist during the working day was 6.95±0.41 prescriptions. At the same time, the average number of e-prescriptions for antibiotics was significantly lower – 1.60±0.19 prescriptions per day. Additionally, the average time to dispense one e-prescription, as reported by the respondents, was 2.63 minutes. The positive aspects of electronic prescribing that were most frequently mentioned in the free-text responses were safety of avoiding defects inherent in paper prescriptions (262) and the reduction in the likelihood of uncontrolled antibiotic consumption (295). However, respondents also described several disadvantages of electronic prescribing of medicines. Conclusions. The results of the study have shown that the introduction of the electronic prescription in the pharmacy practice of Ukraine is an important step towards the digitalization of pharmacy and strengthening control over the turnover of prescription drugs, particularly antibiotics. Most pharmacists support the idea of the e-prescription as a tool for rationalizing the drug dispensing process, reducing abuse, and increasing the transparency of pharmaceutical care.
- 4 September 2025
- Published by National University of Pharmacy in Social Pharmacy in Health Care
- Vol. 11 (3) , 37-47
Open AccessThe introduction of electronic prescriptions in Ukraine as an important component of the electronic healthcare system: the experience of pharmacists
The electronic prescription plays an important role in the digitalization of the healthcare system in Ukraine and is an important tool for managing the supply of medicines. The introduction of e-prescriptions brings the national healthcare system of Ukraine in line with international standards, in particular in the context of European integration obligations. The e-prescription provides transparency, accounting and control of the turnover of prescription drugs, contributes to the rationalization of pharmacotherapy and increases the responsibility of all participants in this process. Aim. To analyze the impact of e-prescriptions on the work of pharmacists, assess the advantages and problems they face during their introduction, as well as determine future development directions for the e-prescription system to improve the efficiency of pharmaceutical services. Materials and methods. The methods used included questionnaire surveys, analysis and synthesis, formal-logical, semantic, comparative, and systemic methods. The data analysis was performed using Microsoft Office Excel and STATISTICA 12. Results and discussion. Our study found that the level of satisfaction among pharmacists with the e-prescription system implemented in Ukraine was quite high, with an average score of 7.79±2.02. According to the survey results, the average value of the number of e-prescriptions dispensed by one pharmacist during the working day was 6.95±0.41 prescriptions. At the same time, the average number of e-prescriptions for antibiotics was significantly lower – 1.60±0.19 prescriptions per day. Additionally, the average time to dispense one e-prescription, as reported by the respondents, was 2.63 minutes. The positive aspects of electronic prescribing that were most frequently mentioned in the free-text responses were safety of avoiding defects inherent in paper prescriptions (262) and the reduction in the likelihood of uncontrolled antibiotic consumption (295). However, respondents also described several disadvantages of electronic prescribing of medicines. Conclusions. The results of the study have shown that the introduction of the electronic prescription in the pharmacy practice of Ukraine is an important step towards the digitalization of pharmacy and strengthening control over the turnover of prescription drugs, particularly antibiotics. Most pharmacists support the idea of the e-prescription as a tool for rationalizing the drug dispensing process, reducing abuse, and increasing the transparency of pharmaceutical care.
- Open Access
- 1 January 2025
- Published by Sumy State University in Eastern Ukrainian Medical Journal
- Vol. 13 (3) , 622-636
PROSPECTS AND PROBLEMS OF DEVELOPMENT, PRODUCTION, AND USE OF BACTERIOPHAGE-BASED MEDICINES
The objective of the study was to investigate the current state of bacteriophages in the fight against multidrug-resistant infections based on international and national scientific publications and to identify the main problems with the use of bacteriophage therapy in medical practice. Methods: In our research, we used general theoretical methods: historical, documentary, analytical, generalization, comparison, systematization and analytical data processing Results: The global medical community has been raising the issue of rational use of antibiotics for more than 30 years and is looking for new ways to combat multidrug-resistant (multidrug-resistant) infections. In particular, the WHO report for 2022 “The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis” indicates that 541 thousand deaths in the European region were caused by multidrug-resistant infections. These fatal infections were caused by Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecium, Streptococcus pneumoniae and Acinetobacter baumannii and their combinations with S. aureus. In Ukraine, the problem of multidrug-resistant infections is particularly relevant in connection with the Russian aggression, during which many militaries and civilians were injured. One of the most effective and promising ways to combat multidrug-resistant infectious diseases is the “forgotten” bacteriophage therapy. The interest of the medical community in bacteriophage therapy is evidenced by the large number of scientific publications on this topic. Thus, in 2009 it was about 2600 publications, and in 2024 their number increased to 20800. During this period, a large number of clinical trials were conducted to prove the efficacy and safety of phage therapy against various infectious agents; in Europe and the United States alone, this number reached more than 200 phase 1 and phase 2 clinical trials. The world's largest research center is the Giorgi Eliava Institute of Bacteriophages, Microbiology, and Virology (Tbilisi, Georgia), which has been researching bacteriophages for more than 100 years. These studies have resulted in a number of medicines with bacteriophage “cocktails” that are successfully used to treat wounds from postoperative interventions, injuries and burns. Today, the technologies for treating bacterial infections developed in Georgia are used in medical institutions in Europe (Belgium, England, Germany, France), as well as in Israel and the United States. Conclusions: Bacteriophage-based medicines are a promising area for the treatment of multidrug-resistant infectious diseases of various etiologies, and are currently used only as a last resort. WHO is collecting evidence on the effectiveness and safety of bacteriophages for the treatment of infectious diseases of various etiologies. The main problem on the way to the development, clinical trials and introduction of bacteriophage-based medicines into medical practice is the international and national good regulatory practices (GLP, GCP, GMP, etc.) that all researchers and manufacturers of medicines must follow. Such regulatory requirements for drug development are not applicable to drugs containing bacteriophages, and therefore new requirements need to be developed or adapted to ensure that new drugs that can save thousands of lives are finally available.
- 1 January 2025
- Published by Sumy State University in Eastern Ukrainian Medical Journal
- Vol. 13 (3) , 622-636
Open AccessPROSPECTS AND PROBLEMS OF DEVELOPMENT, PRODUCTION, AND USE OF BACTERIOPHAGE-BASED MEDICINES
The objective of the study was to investigate the current state of bacteriophages in the fight against multidrug-resistant infections based on international and national scientific publications and to identify the main problems with the use of bacteriophage therapy in medical practice. Methods: In our research, we used general theoretical methods: historical, documentary, analytical, generalization, comparison, systematization and analytical data processing Results: The global medical community has been raising the issue of rational use of antibiotics for more than 30 years and is looking for new ways to combat multidrug-resistant (multidrug-resistant) infections. In particular, the WHO report for 2022 “The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis” indicates that 541 thousand deaths in the European region were caused by multidrug-resistant infections. These fatal infections were caused by Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecium, Streptococcus pneumoniae and Acinetobacter baumannii and their combinations with S. aureus. In Ukraine, the problem of multidrug-resistant infections is particularly relevant in connection with the Russian aggression, during which many militaries and civilians were injured. One of the most effective and promising ways to combat multidrug-resistant infectious diseases is the “forgotten” bacteriophage therapy. The interest of the medical community in bacteriophage therapy is evidenced by the large number of scientific publications on this topic. Thus, in 2009 it was about 2600 publications, and in 2024 their number increased to 20800. During this period, a large number of clinical trials were conducted to prove the efficacy and safety of phage therapy against various infectious agents; in Europe and the United States alone, this number reached more than 200 phase 1 and phase 2 clinical trials. The world's largest research center is the Giorgi Eliava Institute of Bacteriophages, Microbiology, and Virology (Tbilisi, Georgia), which has been researching bacteriophages for more than 100 years. These studies have resulted in a number of medicines with bacteriophage “cocktails” that are successfully used to treat wounds from postoperative interventions, injuries and burns. Today, the technologies for treating bacterial infections developed in Georgia are used in medical institutions in Europe (Belgium, England, Germany, France), as well as in Israel and the United States. Conclusions: Bacteriophage-based medicines are a promising area for the treatment of multidrug-resistant infectious diseases of various etiologies, and are currently used only as a last resort. WHO is collecting evidence on the effectiveness and safety of bacteriophages for the treatment of infectious diseases of various etiologies. The main problem on the way to the development, clinical trials and introduction of bacteriophage-based medicines into medical practice is the international and national good regulatory practices (GLP, GCP, GMP, etc.) that all researchers and manufacturers of medicines must follow. Such regulatory requirements for drug development are not applicable to drugs containing bacteriophages, and therefore new requirements need to be developed or adapted to ensure that new drugs that can save thousands of lives are finally available.
- Open Access
- 30 December 2024
- Published by Private Company Technology Center in ScienceRise: Pharmaceutical Science
- No. 6(52),p. 90-102
Marketing study of selective serotonin reuptake inhibitors for the treatment of post-traumatic stress disorder in military servants and war veterans
The aim of the work: to present the results of a marketing study of medicinal products of the ATC classification group N06AB "Selective serotonin reuptake inhibitors" (SSRIs) in terms of registration and legal status, the state of the wholesale and retail market, presence in socio-economic regulatory lists of medicinal products, as well as to evaluate the results of an anonymous survey of doctors regarding the prescription of SSRIs to military personnel and war veterans with post-traumatic stress disorder (PTSD). Materials and methods. Methods such as analysis, synthesis, comparison, specification, systematization, generalization, and reliability assessment were used; an anonymous survey of 35 psychiatrists and 25 neurologists was conducted regarding the prescription of drugs for patients with PTSD. Results and discussion. It was found that SSRIs should be considered as first-line pharmacotherapy for military personnel with PTSD. At the same time, escitalopram, which, according to the literature, demonstrates the best safety and efficacy indicators, which was preferred by 97% of the surveyed doctors, the market of which showed the greatest growth in terms of assortment and which was most numerously included in the List of Drugs Subject to Reimbursement, remains absent from the updated Unified Clinical Protocol for the Treatment of PTSD. Conclusions. 100% of doctors confirmed the choice of SSRIs, among which, with a probability of type I error α = 0.05, a reliable probability of p ≥ 0.95 regarding the unanimity of responses, psychiatrists most often prescribed escitalopram and sertraline, neurologists - citalopram and escitalopram, in general - escitalopram. As of 01.10.2024, 45 trade names of SSRIs were registered in Ukraine (4 - fluoxetine, 1 - citalopram, 7 - paroxetine, 9 - sertraline, 2 - fluvoxamine, 22 - escitalopram), 80% of the drugs were of foreign origin, 20% of which were manufactured to order by domestic manufacturing companies. Imported drugs came from 15 countries, most of them - from India (28%); among 9 domestic companies, Pharma Start LLC supplies the largest number of medicines (33%). It was found that currently the lowest prices for drugs in Ukraine are offered by the drug booking service Tabletky.UA. The state reimburses the cost of PTSD treatment with the most affordable drugs paroxetine and sertraline (1 trade name each), fluoxetine (3), escitalopram (5). Therefore, given the results of the study, it is recommended to include escitalopram in the Unified Clinical Protocol of Primary and Specialized Medical Care “Acute Stress Reaction. PTSD. Adaptation Disorders”.
- 30 December 2024
- Published by Private Company Technology Center in ScienceRise: Pharmaceutical Science
- No. 6(52),p. 90-102
Open AccessMarketing study of selective serotonin reuptake inhibitors for the treatment of post-traumatic stress disorder in military servants and war veterans
The aim of the work: to present the results of a marketing study of medicinal products of the ATC classification group N06AB "Selective serotonin reuptake inhibitors" (SSRIs) in terms of registration and legal status, the state of the wholesale and retail market, presence in socio-economic regulatory lists of medicinal products, as well as to evaluate the results of an anonymous survey of doctors regarding the prescription of SSRIs to military personnel and war veterans with post-traumatic stress disorder (PTSD). Materials and methods. Methods such as analysis, synthesis, comparison, specification, systematization, generalization, and reliability assessment were used; an anonymous survey of 35 psychiatrists and 25 neurologists was conducted regarding the prescription of drugs for patients with PTSD. Results and discussion. It was found that SSRIs should be considered as first-line pharmacotherapy for military personnel with PTSD. At the same time, escitalopram, which, according to the literature, demonstrates the best safety and efficacy indicators, which was preferred by 97% of the surveyed doctors, the market of which showed the greatest growth in terms of assortment and which was most numerously included in the List of Drugs Subject to Reimbursement, remains absent from the updated Unified Clinical Protocol for the Treatment of PTSD. Conclusions. 100% of doctors confirmed the choice of SSRIs, among which, with a probability of type I error α = 0.05, a reliable probability of p ≥ 0.95 regarding the unanimity of responses, psychiatrists most often prescribed escitalopram and sertraline, neurologists - citalopram and escitalopram, in general - escitalopram. As of 01.10.2024, 45 trade names of SSRIs were registered in Ukraine (4 - fluoxetine, 1 - citalopram, 7 - paroxetine, 9 - sertraline, 2 - fluvoxamine, 22 - escitalopram), 80% of the drugs were of foreign origin, 20% of which were manufactured to order by domestic manufacturing companies. Imported drugs came from 15 countries, most of them - from India (28%); among 9 domestic companies, Pharma Start LLC supplies the largest number of medicines (33%). It was found that currently the lowest prices for drugs in Ukraine are offered by the drug booking service Tabletky.UA. The state reimburses the cost of PTSD treatment with the most affordable drugs paroxetine and sertraline (1 trade name each), fluoxetine (3), escitalopram (5). Therefore, given the results of the study, it is recommended to include escitalopram in the Unified Clinical Protocol of Primary and Specialized Medical Care “Acute Stress Reaction. PTSD. Adaptation Disorders”.
- 12 September 2024
- Published by PHEI "Ivano-Frankivsk Academy Ivana Zolotoustoho" in Good Parson: scientific bulletin of Ivano-Frankivsk Academy of John Chrysostom. Theology. Philosophy. History / Editor-in-Chief R. A. Gorban. Issue 19. Part 2. Ivano-Frankivsk: IFA, 2024. 288 p.
- Vol. 2 (19) , 100-110
Christian education of young people is a guarantee of Ukraine's national security in the context of the Russian-Ukrainian war
The article explores the crucial role of Christian education for the youth in the context of fortifying Ukraine's national security, particularly during the Russian-Ukrainian war. An analysis of research and publications indicates that Christian education contributes to the development of resilient individuals grounded in high moral values, possessing advanced social responsibility, and capable of self-sacrifice for the benefit of the homeland. An essential component involves instilling mercy, tolerance, and patriotism in the youth. The article's objective is to study the impact of Christian education on the youth on Ukraine's national security and to identify ways to strengthen it in wartime conditions. The article provides an example of the successful implementation of Christian education among student youth in collaboration between the Ivano-Frankivsk National Medical University and the clergy of the Ivano-Frankivsk Eparchy of the Ukrainian Greek-Catholic Church. The experience of organizing meetings between priests and youth, as well as educators, in university and outreach settings aimed at the development and strengthening of spirituality among both students and their mentors, is discussed. The main conclusions of the article underscore the importance of Christian education for the reinforcement of Ukraine's national security.
- 12 September 2024
- Published by PHEI "Ivano-Frankivsk Academy Ivana Zolotoustoho" in Good Parson: scientific bulletin of Ivano-Frankivsk Academy of John Chrysostom. Theology. Philosophy. History / Editor-in-Chief R. A. Gorban. Issue 19. Part 2. Ivano-Frankivsk: IFA, 2024. 288 p.
- Vol. 2 (19) , 100-110
Christian education of young people is a guarantee of Ukraine's national security in the context of the Russian-Ukrainian war
The article explores the crucial role of Christian education for the youth in the context of fortifying Ukraine's national security, particularly during the Russian-Ukrainian war. An analysis of research and publications indicates that Christian education contributes to the development of resilient individuals grounded in high moral values, possessing advanced social responsibility, and capable of self-sacrifice for the benefit of the homeland. An essential component involves instilling mercy, tolerance, and patriotism in the youth. The article's objective is to study the impact of Christian education on the youth on Ukraine's national security and to identify ways to strengthen it in wartime conditions. The article provides an example of the successful implementation of Christian education among student youth in collaboration between the Ivano-Frankivsk National Medical University and the clergy of the Ivano-Frankivsk Eparchy of the Ukrainian Greek-Catholic Church. The experience of organizing meetings between priests and youth, as well as educators, in university and outreach settings aimed at the development and strengthening of spirituality among both students and their mentors, is discussed. The main conclusions of the article underscore the importance of Christian education for the reinforcement of Ukraine's national security.
- Open Access
- 30 January 2021
- Published by OU Scientific Route in EUREKA: Health Sciences
- No. 1,p. 86-93
ASSESSMENT OF THE FREQUENCY AND RATIONALITY OF PRESCRIBED MEDICINES IN PATIENTS WITH LIVER CIRRHOSIS
The aim. Assessment of the dynamics of prescribing drugs to patients with liver cirrhosis (LC, K 74), in terms of real clinical practice by methods of clinical and economic analysis. Materials and methods. 355 medical cards of inpatients with cirrhosis of the liver, which were divided into 4 groups depending on the period of stay of patients in the hospital. Methods: compatible retrospective ABC-frequency analysis, which ranked drugs consumed by patients in real clinical practice, according to the frequency of appointment using ABC-segmentation according to the Pareto principle (A – 80 % of drugs appointments: B – 15 %: C – 5 %); VEN-analysis, which divides the consumed drugs on a formal basis depending on the presence / absence of a particular drug in the regulations: vital (Vital or V), necessary (Essential or E) and secondary (Non-essential or N). Results. Cirrhosis of the liver in recent years has been on the 10th - 11th place among the causes of death in the world. The analysis of prescribed drugs to patients with LC in real clinical practice in Ivano-Frankivsk region of Ukraine revealed that over the years doctors prescribed fewer drugs on average per patient (11.4 drugs → 8.8 drugs), which can be considered a positive fact. Among the prescribed drugs, drugs of group A – “Drugs that affect the digestive system and metabolism” prevailed, the share of which increased and was the highest in 2019 – 2020 (2007–2009 – 44.6 %; 2012–2013 – 46.6 %; 2015–2016 – 48.1 %; 2019–2020 – 48.55 %); the share of dietary supplements also increased from 1.65 % to 6.52 %. Conclusions. Combined ABC-frequency and VEN-analyzes showed that the leaders in the years of hospital stay were the following drugs: Sodium chloride, Ademetionine, Pantoprazole, Spironolactone, Thioctic acid, Ornithine, Asparaginate K-Mg, Torasemide, Furosemide. However, the vital class V included only 9–11 % of drugs from the whole set of prescribed drugs, which requires systemic correction in accordance with European recommendations.
- 30 January 2021
- Published by OU Scientific Route in EUREKA: Health Sciences
- No. 1,p. 86-93
Open AccessASSESSMENT OF THE FREQUENCY AND RATIONALITY OF PRESCRIBED MEDICINES IN PATIENTS WITH LIVER CIRRHOSIS
The aim. Assessment of the dynamics of prescribing drugs to patients with liver cirrhosis (LC, K 74), in terms of real clinical practice by methods of clinical and economic analysis. Materials and methods. 355 medical cards of inpatients with cirrhosis of the liver, which were divided into 4 groups depending on the period of stay of patients in the hospital. Methods: compatible retrospective ABC-frequency analysis, which ranked drugs consumed by patients in real clinical practice, according to the frequency of appointment using ABC-segmentation according to the Pareto principle (A – 80 % of drugs appointments: B – 15 %: C – 5 %); VEN-analysis, which divides the consumed drugs on a formal basis depending on the presence / absence of a particular drug in the regulations: vital (Vital or V), necessary (Essential or E) and secondary (Non-essential or N). Results. Cirrhosis of the liver in recent years has been on the 10th - 11th place among the causes of death in the world. The analysis of prescribed drugs to patients with LC in real clinical practice in Ivano-Frankivsk region of Ukraine revealed that over the years doctors prescribed fewer drugs on average per patient (11.4 drugs → 8.8 drugs), which can be considered a positive fact. Among the prescribed drugs, drugs of group A – “Drugs that affect the digestive system and metabolism” prevailed, the share of which increased and was the highest in 2019 – 2020 (2007–2009 – 44.6 %; 2012–2013 – 46.6 %; 2015–2016 – 48.1 %; 2019–2020 – 48.55 %); the share of dietary supplements also increased from 1.65 % to 6.52 %. Conclusions. Combined ABC-frequency and VEN-analyzes showed that the leaders in the years of hospital stay were the following drugs: Sodium chloride, Ademetionine, Pantoprazole, Spironolactone, Thioctic acid, Ornithine, Asparaginate K-Mg, Torasemide, Furosemide. However, the vital class V included only 9–11 % of drugs from the whole set of prescribed drugs, which requires systemic correction in accordance with European recommendations.